I think it should be highlighted that when the patient is referred for a cardiac US, the reason for the referral should be clearly defined _ diagnosis HF or cardiac murmur etc etc
REVIEWER
Dr S Koudstaal Dept of Cardiology University Medical Center Utrecht the Netherlands REVIEW RETURNED 26-Sep-2018
GENERAL COMMENTS
Smeets and co-workers conducted a think-aloud study to increase understanding of diagnostic reasoning by GP's related to the diagnosis of slow-onset heart failure. They found that knowledge on HF definition could be improved, the urge to have a diagnosis (i.e. increase referral rates to cardiology outpatient clinics) was not always present in GPs, and perhaps most importantly, the use of tests which are easily implemented in primary care (e.g. ECG or serum (NT-pro)BNP levels) could be improved. The manuscript is well written and adds value to the scientific field aimed to expedite heart failure diagnosis in primary care. I have some minor comments:
1. ESC guideline is cited as guideline for GPs but usually there is a GP based (national) guideline, for example NICE in the UK or NHG standard in the Netherlands. It probably shows my unfamiliarity in this field but is there not an equivalent available in Belgium? If absent, shouldn't that be discussed as one of the factors that account at least in part the knowledge gap in primary care as shown in this paper?
2. Can influencing factors listed in tables 2 to 4 be weighed somehow. In other words, how many GPs mentioned the overlap with co-morbidities and so on. Percentages would be welcome.
3. One GP mentioned lack of reimbursement for BNP, which to me -especially because it is recommended in an international guideline as a valuable tool-is contradictory. Please elaborate on this. Are there financial incentives for a GP not to use this test?
REVIEWER

Nicholas Jones
University of Oxford, Nuffield Department of Primary Care Health Sciences, UK REVIEW RETURNED 05-Oct-2018
GENERAL COMMENTS
Thanks -this is an interesting study and I believe an important area of research for primary care and also health policy makers. The 'Think Aloud' approach provides useful insights into clinicians thought process and the methodological approach reflects the explorative nature of the research. Suggested revisionsp4 10-11 'Slow-onset' heart failure (HF) is not a term that I have seen widely used in English-language literature on this topic. HF is categorised as either 'acute', 'chronic' or 'stable' based on ESC guidelines and I would included a mention of these delineations in the introduction. p6 1-2. The claim to have a representative sample of GPs across those variables seems over-stated given only 14 interviewed. The sample size is not justified -?pragmatic ?felt there was saturation of responses. p6 46-48. Do you think the fact the author making the recordings might have influenced the way the GPs described their decision making process? p7 14-16. The 'fine-tuning' process of data collection should be described in more detail or if of little relevance removed to just say the data collection techniques were piloted under the supervision of a qualitiatve research expert. p7 -could the decision tree of descriptive themes be included in the appendices or supplemental online material p8 -It looks from the 
VERSION 1 -AUTHOR RESPONSE
Reviewer 1:
This is an interesting study which provides useful insight into the heart failure diagnostic process in general practice. The study used think aloud methodology and case study to explore the diagnostic reasoning in 14 GPs. This is a valuable addition to the literature in this field. I would recommend for publication with minor revisions. Details comments below.
1. Abstract: Methods could be more clearly described e.g. 'clarify some thoughts'.
Response: The authors fully agree with this important remark. The Method section in the Abstract was adapted:
"This was followed by an interview to get a deeper insight in their reasoning."
2. Results need to be more specific regarding findings of the study. 'Patient and social factors' and 'influenced by many factors' isn't clear. Conclusion can then follow more easily -at the moment some of the results are listed in conclusions.
Response: The authors want to thank the reviewer for this valuable feedback. The Result and Conclusion section in the Abstract was revised as follows:
"Results We developed a conceptual diagnostic model, based on three important reasoning steps. First, GPs assessed the likelihood of CHF based on the presence or absence of HF signs and symptoms. However, this approach had serious limitations since GPs experienced many barriers in their clinical assessment, especially in comorbid elderly. Second, if CHF was considered based on step one, the main influencing factor to take further diagnostic steps was the GPs' perception of the added value of a validated CHF diagnosis in that specific case. Third, the choice and implications of these further diagnostic steps (NT-proBNP, electrocardiography and/or cardiac ultrasound) were influenced by the GPs' knowledge about these tests and the quality of the cardiologists' reports.
Conclusion This think-aloud study identified the factors that influenced the diagnostic reasoning about CHF in general practice. As a consequence, targets to improve this diagnostic reasoning were withheld: a paradigm shift towards an earlier and more comprehensive risk assessment with among others access to natriuretic peptide testing and convincing GPs of the added value of a validated HF diagnosis."
3. Strength and limitations: Second bullet 'clarify some thoughts and strengthen data collection' doesn't explain what was done -could this be explained in a different way?
Response: This second bullet point was shortened to one sentence on editorial request and is now limited to the motivation to choose for the think-aloud design.
"The think-aloud design is ideal to capture a sequence of thoughts involved in decision-making."
4. is a full stop needed after 'enhancement' needed in fourth bullet point?
Response: The authors thank the reviewer for this helpful comment. Since bullet points should be limited to one sentence, the fourth bullet point was adapted as follows:
• "The QUAGOL was used as a guide to enhance the data-analysis since it promotes thorough (re)reading, thinking, and discussion about the research data before starting the actual coding process."
5. Introduction: Page 4 Line 30 -use acronym 'HF' rather than 'heart failure' as spelt out already in first sentence.
Response: The authors fully agree with this remark. "Heart failure" was replaced by "HF".
6. Method: Page 5 Line 49 '…consent procedures were deployed by all participant GPs' needs rewording.
Response: The authors thank the reviewer for this important remark. The Method section was restructured as follows:
"Before the think-aloud sessions, all participant GPs were asked informed consent based on written information about the aim and methods of the study. There was no remuneration provided for participation in the study." Response: The authors thank the reviewer for this valuable feedback. The paragraph was rewritten to clarify the method we used.
"Since HF patients are often not registered as such in the GPs' electronic health record (EHR), we first performed a clinical audit in each EHR to identify possible HF patients. This clinical audit consisted of the search on a registered (coded or free text) diagnosis of HF, combined with the search on coded or free text diagnoses of risk factors for HF, HF symptoms and signs and combinations of HF medication (Supplemental file 1). The list of all possible HF patients was then presented to each treating physician and they were asked to judge which patients had HF or not (0/1) and grade how certain they were about the diagnosis (Likert scale ranging from 0-10-25-50-75-90-98%), based on their knowledge of the patient file. Afterwards, four patients of each GP were chosen at random for the think-aloud session: two of each binary code (HF 0/1) and, in each category, one with a high grade of certainty (i.e., >75%) and one with a low grade of certainty (i.e., <75%). The order of the cases was chosen at random for all participants. The GPs were asked to think-aloud about why they did or did not appoint the HF diagnosis in their own real-world patients based on the patient file in the EHR."
Page 7 -explain what QUAGOL is briefly.
Response: The authors fully agree with this remark. The following was added to the Method section:
"The Qualitative analysis guide of Leuven (QUAGOL) was held as a guide for the data analysis.1 The QUAGOL is a theory-and practice-based guide that offers a comprehensive method to guide the process of qualitative data analysis within the grounded theory approach. It promotes thorough (re)reading, thinking, and discussion about the research data before starting the actual coding process.1" 9. Need more explanation about healthcare setting (private, public) as when get to results this is important to know.
Response: The authors want to thank the reviewer for this interesting comment. This is indeed relevant information. The following was added to the Method section:
"The setting of this think-aloud study was general practice in Belgium. All general pratices in Belgium form of the public health care system." … "Initially, three family practices were selected, 2 urban and 1 more rural. One of the urban practices was a district health centre that was financed at practice-level and receives a fee for each registered patient. The other practices work in a pay-for-performance system where GPs get paid for each patient that consults them. The latter is the most common system in Belgium." 10. Results: Explain average -?median ?mean.
Response: The authors want to thank the reviewer for this fair point. We revised the Results section as follows:
"The 14 participants had been specialists in family medicine for a median of 10 years (interquartile range 1.8-22). Their mean age was 40 ±13 years old, and 9 of them were women (64%) ( 13. Page 10 Line 40 onwards -quote about compliance is more about management and taking medication rather than diagnosis. The methods need to be clearer that the study looked at diagnosis or management too?
Response: The authors fully agree with the reviewer's comment. Our research question concerns indeed the diagnosis of chronic heart failure, not the management. We added this quote to illustrate that GPs dealt differently with non-compliant patients but after a team discussion, we came to the conclusion that this quote is too far from our research question, so we deleted it from the Result section.
14. Page 11 Line 27 ?'conversely' rather than 'reversely'
Response: The authors fully agree with this remark and changed 'reversely' in 'conversely'.
15. Discussion: Page 16 Line 31 -no GP mentioned AHA so you need to talk about this and explain what it is, rather than state GPs assessed HF likelihood based on it which isn't quite true.
Response: The authors thank the reviewer for this important remark. This paragraph was restructured to clarify this matter.
"Every GP assessed the likelihood of HF as a first step. The arguments GPs used in their assessment coincided with the concept of the cardiovascular continuum or the HF stages of the American Heart Association (AHA) guideline. These concepts describe HF as a syndrome that progresses from asymptomatic structural heart disease in patients with CV risk factors to symptomatic HF, making this likelihood assessment a valuable approach."
16. Also need to spell out and explain what NYHA is.
Response: The authors appreciate the reviewer's helpful feedback. The sentence was adapted to spell out NYHA and explain the significance of NYHA stage III-IV. "Furthermore, it was shown that 77% of Belgian GP patients are already in New York Heart Association (NYHA) stage III-IV and thus unmistakably symptomatic at the time of HF diagnosis."
17. Page 17 Line 3 early intervention in asymptomatic patients is not clear cut so don't overstate
Response: The authors thank the reviewer for the important feedback. We revised the literature and agree that the evidence for pharmacological treatment in asymptomatic patients with regard to morbidity and mortality, applies especially to Stage B patients and that a long-term reduction is an overstatement since studies only ran for maximum 12 months. The statement was adapted as follows:
"Early intervention in HF Stage B (asymptomatic structural heart disease) patients led to a reduction in morbidity and mortality.2"
18. Page 17 -slight rewording needed 'reckon' and 'plead' not in common use
Response: The authors thank the reviewer for these suggestions. Response: The authors agree with the reviewer that this is exceptional, however this had probably to do with the involvement of three out of four practices in academic teaching and/or research. As described in the Method section the interviewer was trained in two of the participating urban practices increasing their willingness to participate. In the third rural practice two GPs were involved in academic teaching and/or research and convinced their fellow GPs to participate. Therefore, as described a fourth rural practice was contacted with GPs not involved in academic teaching or research and, rather by chance, we also had a 3 out of 3 success rate in recruitment there. To explain our high recruitment success rate, the following was added to the limitations section:
"In this survey, there was also a higher fraction of participant GPs involved in academic teaching and/or research, explaining our recruitment success rate of 100%."
21. Conclusions: Page 20 -add in the issue of referral to cardiologists and the lack of trust/cooperation?
Response: The authors agree that this is an important issue. It was added to the Conclusion Section as follows:
"As a consequence, targets to improve this diagnostic reasoning were identified: a paradigm shift towards earlier risk assessment, rethinking the HF definition in the very old, promoting access to NTproBNP and convincing GPs of the added value of an objectified HF diagnosis through a better cooperation with cardiologists."
The authors want to thank the reviewer for the thorough reading of the paper and the useful feedback! Reviewer 2:
Well written and applicable study.
1. Sometimes though HF can occur in the presence of a normal ECG. It, however, is an important investigation which the GP can do and most ECG machines have computer analysis.
Response: The authors fully agree with this remark. Therefore, we stated ECG is recommended by all guidelines as "further diagnostic test" in the Discussion section. It is rather remarkable that GPs in our study hardly mentioned it. Therefore, we discussed two possible shortcomings of ECG in the hands of GPs being a lack of experience with the interpretation and its use (sometimes this also include outdated material because they do not use it that often -can the computer analysis be trusted then?) and the high prevalence of abnormal ECG findings in elderly.
2. In pts with dyspnea and suspected HF, a NT pro BNP ( or BNP) is more useful as an initial investigation than cardiac US.
Response: The authors fully agree with this remark and we promote its use in general practice as one of our main conclusions. Sadly, in Belgium its use is not widespread because of a lack of reimbursement. This means the patient has to pay for the test (+/-25 euro) and it seems that this is experienced as a barrier to use natriuretic peptides in the diagnosis of HF. This information was added to the Discussion section:
"In Belgium, the cost of natriuretic peptide testing is relayed on the patient (+/-25 euro per test) due to an impasse in the negotiations with clinical biologists."
3. I think it should be highlighted that when the patient is referred for a cardiac US, the reason for the referral should be clearly defined _ diagnosis HF or cardiac murmur etc
Response: The authors fully agree with this suggestion and considered adding this to the Discussion section. However, this topic was not mentioned by any of the GPs in the interviews. Consequently, we do not know whether they refer patients with a clinical question and background to cardiologists. This could rather be a theme in a qualitative study about experiences of cardiologists in the diagnosis of HF…
The authors want to thank the reviewer for the thorough reading of the paper and the useful feedback! Reviewer 3:
Response: The authors want to thank the reviewer for this useful suggestion! There is indeed a GPbased national guideline about HF and an important difference with the ESC guideline is that the use of natriuretic peptides is not actively promoted since it is not reimbursed in Belgium. This information was added to the Discussion section.
"Belgian GPs rather use the national GP guideline about CHF published in 2011. Recommendations are generally in line with the ESC HF guideline but the use of natriuretic peptides is not actively promoted in this guideline since the test is not reimbursed in Belgium. 3 The paradigm shift to an earlier risk assessment should be more widely disseminated in practice. However, access to natriuretic peptides is indispensable to achieve this.4-7"
